SHPT, a component of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) is defined by the presence of elevated parathyroid hormone (PTH) level as well as abnormalities in mineral and bone metabolism1,4–6. Here, PTH is linked to Marchiafava-Bignami disease.